Search - tctmd.com

Displaying 161 - 180 of 491

Sort: Relevancy | Date

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection Open With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.” configuration options With no difference between nighttime and morning dosing, “patients can take their tablets whenever it’s convenient.”

News Conference News ESC 2022

TIME of Antihypertensive Dose Doesn’t Matter for CV Protection

August 26, 2022

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

News Daily News

Antibiotics Before Invasive Dental Work Helpful in High-Risk Patients

August 22, 2022

What’s Going to Be Hot at ESC 2022?

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

August 22, 2022

US, European Hypertension Guidelines: More Alike Than Different

News Daily News

US, European Hypertension Guidelines: More Alike Than Different

August 17, 2022

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

News Daily News

INTEGRITTY Aims to Shine a Light on Research Bias, Including in LM Disease

Michael O'Riordan

July 12, 2022

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

News Daily News

Few Adults Eligible for Primary Prevention With Statins in Latest ESC Guidelines

Michael O'Riordan

July 06, 2022

COVID-19: TCTMD’s Dispatch for June Week 2

News Daily News

COVID-19: TCTMD’s Dispatch for June Week 2

June 06, 2022

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

News Daily News

COVID-19 Had Broad Global Effects on CV Care, Review Affirms

June 02, 2022

TCTMD’s Top 10 Most Popular Stories for May 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

June 01, 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

News Conference News EAS 2022

FH Patients Face Unchanging Acute MI Risks Plus Very Late Diagnoses

Michael O'Riordan

May 26, 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

New HF Guidelines Stress Four Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

News Conference News ACC 2022

New HF Guidelines Stress Four-Drug Approach, ‘HFmrEF,’ Amyloidosis Options, and More

April 01, 2022

April 2022 News Roundup

News Opinion CV Team Dispatch

April 2022 News Roundup

April 01, 2022

Bloodlines: How Far Should Cardiologists Go in Treating Family?

News Features

Bloodlines: How Far Should Cardiologists Go in Treating Family?

March 10, 2022

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

News Daily News

Statin Intolerance Overestimated—Only ‘Small Number’ Get Side Effects: Meta-analysis

Michael O'Riordan

February 18, 2022

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

News Daily News

Absence of CAC May be Protective Even in Patients With Very High Cholesterol

Michael O'Riordan

February 14, 2022

February 2022 News Roundup

News Opinion CV Team Dispatch

February 2022 News Roundup

February 01, 2022

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

News Features

World-wise: As In-Person Meetings Resume, Global Voices Hope to Be Heard

December 13, 2021

COVID-19: TCTMD’s Dispatch for December Week 1

News Daily News

COVID-19: TCTMD’s Dispatch for December Week 1

December 06, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.